Company Search:
Advanced Search
Sponsored Links
Compugen Ltd Company Snapshot
Compugen Ltd operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Compugen Ltd with three other pharmaceutical manufacturers in Middle East: Arab Drug Company for Pharmaceuticals and Chemical Industries SAE of Egypt (2018 sales of 382.93 million Egyptian Pounds [US$24.27 million] ), Memphis Pharmaceutical & Chemical Industries of Egypt (343.36 million Egyptian Pounds [US$21.76 million] ), and Hayat Pharmaceutical Industries Company PSC which is based in Jordan (14.12 million Jordanian Dinars [US$19.91 million] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Compugen Ltd
  Stock Performance Chart for Compugen Ltd
  Stock Data: Recent Stock Performance:
  Current Price (1/17/2020): 21.14
(Figures in Israel Shekels)
1 Week -0.8%   13 Weeks 8.2%  
4 Weeks 53.2%   52 Weeks 80.8%  
Compugen Ltd Key Data:
  Ticker: CGEN Country: Israel
  Exchanges: NAS OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 64,167,220
(Year Ending Jan 2019).
Employees: 89
  Currency: Israel Shekels Market Cap: 1,265,499,743
  Fiscal Yr Ends: December Shares Outstanding: 59,849,784
  Share Type: Ordinary Closely Held Shares: 2,375,168
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.